• Second Opinion
  • Posts
  • How GLP-1s are transforming binge eating and big food

How GLP-1s are transforming binge eating and big food

An unexpected consequence of these blockbuster drugs

Author

Leslie Schrock
April 03, 2025

A staggering one in eight Americans has tried GLP-1s. We know that, in addition to weight loss, they also help reduce the risk of conditions like type 2 diabetes and cardiovascular disease, and have a role in preventing neurodegenerative diseases like Alzheimer’s or Parkinson’s. But GLP-1 use impacts a common and less discussed condition—binge eating. And the effects are transforming big food.

As a former food entrepreneur, I know more than I wish I did about that profoundly flawed system. I’ve followed it closely for over a decade, and believe that its moment of reckoning is finally here, and not for the reasons I expected.

Become a paid supporter to see more

This newsletter is made possible by the paid contributions of users like yourself. Join hundreds of other healthcare professionals, investors, and entrepreneurs that have access to all of our analysis, reporting, opinions and interviews

Already a paying subscriber? Sign In.

A subscription gets you:

  • • Subscriber-only posts and full archive
  • • Post comments and join the community
  • • Deep dive content and analysis
  • • Access to remote and in-person events

Reply

or to participate.